Search

everythinglearnresearchcommunity

for

Search:↓

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Taking triterpenoids from Ganoderma lucidum over a long time can help slow down brain aging and improve overall health in mice.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Eating apples can help prevent heart disease, cancer, and other conditions because they have healthy plant chemicals.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Fructus Malvae may help with diabetes, tumors, and hair loss due to its various active compounds.

Manipulating cell cleanup processes could help treat hair loss.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Many popular skincare products claim to prevent aging but lack strong evidence to prove their effectiveness and safety.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

A man with a rare lung-focused form of hypereosinophilic syndrome improved with steroid treatment.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Syphilis is becoming more common and remains a major health problem due to challenges in prevention and treatment.